Ligand validation:6HPZ

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6HPZ_EDO_A_201	26%	100%	0.278	0.921	0.14	0.05	-	-	0	0	100%	1
6HPZ_EDO_A_202	19%	93%	0.176	0.768	0.18	0.32	-	-	0	0	100%	1
6HQ0_EDO_A_201	83%	94%	0.091	0.95	0.22	0.2	-	-	0	0	100%	1
6HT0_EDO_A_208	80%	100%	0.108	0.957	0.07	0.07	-	-	0	0	100%	1
6T1I_EDO_A_202	76%	95%	0.096	0.932	0.21	0.17	-	-	0	0	100%	1
6T1J_EDO_A_203	71%	100%	0.148	0.971	0.08	0.08	-	-	0	0	100%	1
6T1N_EDO_A_202	61%	99%	0.148	0.936	0.16	0.07	-	-	0	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
7CJO_EDO_B_1210	100%	83%	0.038	0.99	0.47	0.32	-	-	0	0	100%	1
4O78_EDO_A_202	100%	86%	0.043	0.992	0.4	0.33	-	-	0	0	100%	1
6QRS_EDO_A_401	100%	83%	0.045	0.991	0.47	0.31	-	-	0	0	100%	1
1EB6_EDO_A_1180	100%	64%	0.041	0.986	0.62	0.72	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.